Quantcast

Latest Phytomedics Inc. Stories

2010-11-09 09:51:00

JAMESBURG, N.J., Nov. 9, 2010 /PRNewswire/ -- Phytomedics, Inc., a transformational healthcare company developing a novel portfolio of drugs and consumer products solely derived from plant sources, announced today that it has been awarded a grant in the amount of $244,000 under the Qualifying Therapeutic Discovery Project (QTDP) Program to advance the development of its lead product PMI-001 for Rheumatoid Arthritis. PMI-001 is presently in Phase 2b/3 development. (Logo:...

2010-06-16 06:07:00

JAMESBURG, N.J., June 16 /PRNewswire/ -- Phytomedics Inc., a clinical stage biopharmaceutical company developing a novel portfolio of drugs and consumer products solely derived from plant sources, today announced that Dr. Laurie Smaldone, MD, President and Chief Executive Officer, will deliver an investor presentation at the 2010 New York Venture Summit, on June 17th, 2010, held at New York's Hotel Pennsylvania, 401 Seventh Avenue, New York, N.Y. Dr. Smaldone's presentation will take...

2010-06-07 09:46:00

JAMESBURG, N.J., June 7 /PRNewswire/ -- Phytomedics Inc., a clinical stage biopharmaceutical company developing a novel portfolio of drugs and consumer products solely derived from plant sources, announces the appointment of Dr. Jacques-Pierre Moreau to its board of directors. "We are honored to have an experienced industry veteran of Dr. Moreau's caliber join the Phytomedics board of directors," said Dr. Laurie Smaldone MD, President and CEO of Phytomedics Inc. "Dr. Moreau is an...

2010-04-28 10:03:00

JAMESBURG, N.J., April 28 /PRNewswire/ -- Phytomedics Inc., a clinical stage biopharmaceutical company developing a novel portfolio of drugs and consumer products solely derived from plant sources, today announced that Dr. Laurie Smaldone, MD, President and Chief Executive Officer, will deliver a corporate presentation at the BIO 2010 International Convention on Thursday, May 6th, at McCormick Place Convention Center in Chicago. Dr. Smaldone's presentation will take place at 9:30 a.m. CDT...

2009-08-19 06:25:00

JAMESBURG, N.J., Aug. 19 /PRNewswire/ -- Phytomedics Inc. today announced the publication of the results of a 6 month, Phase 2b clinical trial with an extract of Tripterygium wilfordii Hook F (TwHF) to be developed as PMI-001, in patients with rheumatoid arthritis, in the August 18, 2009 issue of the Annals of Internal Medicine. In an article entitled "Comparison of Tripterygium wilfordii Hook F versus Sulfasalazine in the Treatment of Rheumatoid," the TwHF extract or thundergod vine was...


Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.